Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00510367 · ClinicalTrials.gov registry record · Early Phase 1
Primary Breast Cancer Occurring Concomitant With Pregnancy
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 61
- Enrollment target
NCT00510367: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00510367 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00510367, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn the results of multimodality (chemotherapy, surgery and radiation therapy) treatment of primary breast cancer that occurs at the same time as pregnancy. Researchers want to evaluate the outcome of labor and delivery as well as evaluate the long-term health outcomes of children exposed to chemotherapy while in their mother's womb.
Interventions
- DRUG Cyclophosphamide
- DRUG Doxorubicin
- DRUG 5-Fluorouracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2001-08-07 |
| Est. Completion | 2020-07-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00510367
The ClinicalTrials.gov registry entry for NCT00510367 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cyclophosphamide is the first listed.
NCT00510367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00510367 about?
NCT00510367 is a clinical study titled "Primary Breast Cancer Occurring Concomitant With Pregnancy". The goal of this clinical research study is to learn the results of multimodality (chemotherapy, surgery and radiation therapy) treatment of primary breast cancer that occurs at the same time as pregnancy. Researchers want to evaluate the outcome of labor and delivery as well as evaluate the long-te...
What is the current status of trial NCT00510367?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 61 participants. The study started on 2001-08-07. Estimated completion is 2020-07-08.
What interventions are being tested in trial NCT00510367?
The interventions under investigation include: Cyclophosphamide (DRUG), Doxorubicin (DRUG), 5-Fluorouracil (DRUG).
Who is sponsoring clinical trial NCT00510367?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.